Bloods have doubled over past few months and was Tod yesterday I’ve relapsed. I’m 8 years post FCR and now being prepped to commence one of three options in the next few weeks after ct scan etc. Options are 1/ Venetoclax. 2 years 2/ Ibrutinib indefinitely. Or 3 Acalabrutinib indefinitely. I’m sure these are correct. Mind is swimming at the minute. Does anyone have any experience or advice.
Billy.
Written by
Billys60
To view profiles and participate in discussions please or .
8 years is great. I am 3 years post FCR. What are ur markers?
Get second opinion. Venetoclax has been a great drug. I personally would not want Ibrutinib due to Afib issue & fact you take it till it stops working. Acalabrutinib has less side effects. Everyone is different so it's a big decision. 🙏💕
I would pick acalabrutinib over the other two, keeping in mind I am no expert.
With Cll we often cobble treatments together. Since Cll drugs are evolving and getting better each day, I lean towards kicking the can down the road with the drug that does the least harm. I would pick acalabrutinib over ibrutinib, so the real choice for me would be between venetoclax and ibrutinib.
Venetoclax is a great Cll drug and in my view, a more powerful drug than acalabrutinib. And it can be a limited duration therapy. So why then acalabrutinib?
Number one is we have a lot of data about how drugs like acalabrutinib can sequence to venetoclax when they fail, but less data about whether going from venetoclax to a btk drug like acalabrutinib works as well.
Venetoclax can be much more neutrophil depleting than acalabrutinib since it is so powerful.
So I like the idea of going with an easy, do the least harm drug like acalabrutinib and keeping venetoclax in my back pocket. I am on acalabrutinib right now with almost zero side effects and am considering adding venetoclax.
By kicking the can down the road with drugs that do the least harm, we will be in better shape when the time for our next treatment comes.
All that said, it’s a close call. I wouldn’t argue much with anyone who picked venetoclax. I do think most Cll doctors these days would choose acalabrutinib over ibrutinib. A very recent study seems to confirm acalabrutinib works just as well with less side effects.
And please note that when you click on any other posting, the contents of the box labeled "Related Posts" will probably change to match the words in the title of the page.
Hi Billy, I read your blog at Macmillan, from which I guess you wouldn't want to repeat FCR, an option mentioned by one of the blood cancer charities (sorry I forget which).
I believe Ven plus Ritux is another time-limited option.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.